NPI: 1326482928 · FLORENCE, SC 29505 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/25/2013
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (SR DIRECTOR LICENSURE&CERTIFICATION) |
| NPI Enumeration Date | 04/25/2013 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 2,440 | $84K |
| 2019 | 7,630 | $69K |
| 2020 | 10,517 | $60K |
| 2021 | 8,407 | $63K |
| 2022 | 8,496 | $49K |
| 2023 | 4,960 | $16K |
| 2024 | 2,271 | $40K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90935 | Hemodialysis procedure with single evaluation by a physician | 18,989 | 1,959 | $261K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 7,755 | 1,128 | $81K |
| A4657 | Syringe, with or without needle, each | 2,560 | 1,602 | $27K |
| J1756 | Injection, iron sucrose, 1 mg | 2,539 | 762 | $5K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 262 | 143 | $4K |
| J1270 | Injection, doxercalciferol, 1 mcg | 5,880 | 709 | $1K |
| 83970 | 951 | 810 | $767.61 | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 266 | 26 | $338.14 |
| 82728 | 626 | 510 | $212.79 | |
| 83550 | 566 | 456 | $160.22 | |
| 83540 | 593 | 471 | $124.70 | |
| 85041 | 1,261 | 1,050 | $95.88 | |
| 85048 | 1,264 | 1,050 | $92.75 | |
| 85045 | 174 | 141 | $11.70 | |
| 86706 | 14 | 12 | $6.84 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 45 | 38 | $2.47 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 976 | 337 | $0.00 |